Berberine Hydrochloride

Basic Information

Item Value
DrugBank ID DB04115
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 severe pre-eclampsia KG + DL
2 mild pre-eclampsia KG + DL
3 monocytic leukemia KG + DL
4 multiple endocrine neoplasia KG + DL
5 preeclampsia/eclampsia KG + DL
6 spermatocytic seminoma KG + DL
7 placental hemangioma KG + DL
8 tubular variant testicular seminoma KG + DL
9 gestational trophoblastic neoplasm KG + DL
10 toxemia of pregnancy KG + DL
11 hereditary neurocutaneous angioma KG + DL
12 kaposiform hemangioendothelioma KG + DL
13 female infertility KG + DL
14 acute lymphoblastic leukemia (disease) KG + DL
15 actinic cheilitis KG + DL
16 Sjogren syndrome KG + DL
17 uveal coloboma-cleft lip and palate-intellectual disability KG + DL
18 prolapse of lacrimal gland KG + DL
19 trichotillomania KG + DL
20 Tourette syndrome KG + DL
21 transverse vaginal septum KG + DL
22 longitudinal vaginal septum KG + DL
23 bone Paget disease KG + DL
24 primary peritoneal carcinoma (disease) KG + DL
25 preeclampsia KG + DL
26 46,XY disorder of sex development due to testicular steroidogenesis defect KG + DL
27 intestinal polyposis syndrome KG + DL
28 hydatidiform mole, recurrent KG + DL
29 gestational uterine corpus choriocarcinoma KG + DL
30 fallopian tube gestational choriocarcinoma KG + DL
31 VACTERL with hydrocephalus KG + DL
32 hibernoma KG + DL
33 gestational ovarian choriocarcinoma KG + DL
34 partial hydatidiform mole KG + DL
35 tall cell variant thyroid gland papillary carcinoma KG + DL
36 thyroid gland spindle cell tumor with thymus-like differentiation KG + DL
37 multicentric papillary thyroid carcinoma KG + DL
38 trabecular follicular adenocarcinoma KG + DL
39 columnar cell variant thyroid gland papillary carcinoma KG + DL
40 thyroid gland papillary and follicular carcinoma KG + DL
41 myeloproliferative neoplasm KG + DL
42 lipoma KG + DL
43 epithelioid hemangioendothelioma KG + DL
44 megalencephaly (disease) KG + DL
45 differentiated thyroid carcinoma KG + DL
46 pleomorphic lipoma KG + DL
47 intraorbital meningioma KG + DL
48 cerebral convexity meningioma KG + DL
49 candidiasis KG + DL
50 parasagittal meningioma KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.